LRRC26 and prostate cancer: In prostate cancer cells, the γ1 subunit, LRRC26 elicits a large negative shift in the voltage dependence of KCa1.1, thereby activating KCa1.1 at physiological voltages and resting intracellular Ca2+ levels (Yan and Aldrich, 2010).